Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant Human Porphobilinogen Deaminase

EU orphan designation number: EU/3/02/103   
Active ingredient: Recombinant Human Porphobilinogen Deaminase
Indication: Treatment of acute intermittent porphyria
Sponsor: Zymenex A/S
Roskildevej 12C, 3400 Hillerød, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2002 Orphan designation EMEA/OD/083/01 (2002)2231 of 12/06/2002
04/02/2005 Change of name and/or address of sponsor